5 Reasons Eli Lilly Just Keeps Rising

JHVEPhoto When I put a Buy rating on Eli Lilly (NYSE:LLY) a quarter ago, I didn’t believe that it was an investment for the short-term, but that it had potential from the longer term perspective. As it happens, it turned out to be one for short-term gains too, with an over 17% increase in price since I wrote. The stock is now up by 56% year-to-date [YTD], far outstripping the just 7% rise in the S&P 500 Health Care Index in this time.   Price Chart (Source: Seeking Alpha) On the face of it, this is mind ...